SENESTECH INC(NASDAQ:SNES) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to SNES. SNES was compared to 198 industry peers in the Pharmaceuticals industry. SNES may be in some trouble as it scores bad on both profitability and health. SNES shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SNES has reported negative net income.

In the past year SNES has reported a negative cash flow from operations.

In the past 5 years SNES always reported negative net income.

SNES had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -188.65%, SNES is doing worse than 86.87% of the companies in the same industry.

The Return On Equity of SNES (-246.28%) is worse than 72.22% of its industry peers.

		Industry Rank	Sector Rank
ROA	-188.65%
ROE	-246.28%
ROIC	N/A

ROA(3y)-145.81%

ROA(5y)-129.68%

ROE(3y)-183.8%

ROE(5y)-169.9%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SNES's Gross Margin of 54.07% is fine compared to the rest of the industry. SNES outperforms 64.14% of its industry peers.

In the last couple of years the Gross Margin of SNES has grown nicely.

SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	54.07%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y10.57%

GM growth 5Y13.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for SNES has been increased compared to 1 year ago.

SNES has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, SNES has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -59.68, we must say that SNES is in the distress zone and has some risk of bankruptcy.

SNES has a Altman-Z score of -59.68. This is amonst the worse of the industry: SNES underperforms 92.93% of its industry peers.

A Debt/Equity ratio of 0.08 indicates that SNES is not too dependend on debt financing.

SNES has a Debt to Equity ratio (0.08) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Altman-Z	-59.68

ROIC/WACCN/A

WACC9.9%

2.3 Liquidity

A Current Ratio of 5.01 indicates that SNES has no problem at all paying its short term obligations.

The Current ratio of SNES (5.01) is better than 73.23% of its industry peers.

SNES has a Quick Ratio of 3.60. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.

SNES has a better Quick ratio (3.60) than 62.63% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.01
Quick Ratio	3.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.76% over the past year.

The Revenue has grown by 55.40% in the past year. This is a very strong growth!

Measured over the past years, SNES shows a very strong growth in Revenue. The Revenue has been growing by 67.70% on average per year.

EPS 1Y (TTM)96.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.49%

Revenue 1Y (TTM)55.4%

Revenue growth 3Y45.73%

Revenue growth 5Y67.7%

Sales Q2Q%69.83%

3.2 Future

Based on estimates for the next years, SNES will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.28% on average per year.

Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 76.45% on average per year.

EPS Next Y36.16%

EPS Next 2Y18.6%

EPS Next 3Y14.28%

EPS Next 5YN/A

Revenue Next Year103.47%

Revenue Next 2Y91.38%

Revenue Next 3Y76.45%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SNES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

SNES's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y18.6%

EPS Next 3Y14.28%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SNES!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SENESTECH INC

NASDAQ:SNES (5/2/2025, 8:23:41 PM)

After market: 2.39 -0.01 (-0.42%)

2.4

+0.18 (+8.11%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)03-12 2025-03-12/amc

Earnings (Next)05-07 2025-05-07

Inst Owners2.2%

Inst Owner Change0%

Ins Owners0.02%

Ins Owner Change0%

Market Cap4.27M

Analysts82.86

Price Target10.2 (325%)

Short Float %6.76%

Short Ratio0.9

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)28.42%

Min EPS beat(2)20.26%

Max EPS beat(2)36.58%

EPS beat(4)3

Avg EPS beat(4)14.67%

Min EPS beat(4)-3.81%

Max EPS beat(4)36.58%

EPS beat(8)5

Avg EPS beat(8)-5.56%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-24.67%

Min Revenue beat(2)-30.53%

Max Revenue beat(2)-18.81%

Revenue beat(4)0

Avg Revenue beat(4)-15.43%

Min Revenue beat(4)-30.53%

Max Revenue beat(4)-5.16%

Revenue beat(8)0

Avg Revenue beat(8)-21.15%

Revenue beat(12)0

Avg Revenue beat(12)-24.04%

Revenue beat(16)2

Avg Revenue beat(16)-16.73%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.3
P/FCF	N/A
P/OCF	N/A
P/B	1.7
P/tB	1.7
EV/EBITDA	N/A

EPS(TTM)-9.97

EYN/A

EPS(NY)-6.36

Fwd EYN/A

FCF(TTM)-3.44

FCFYN/A

OCF(TTM)-3.39

OCFYN/A

SpS1.04

BVpS1.41

TBVpS1.41

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-188.65%
ROE	-246.28%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	54.07%
FCFM	N/A

ROA(3y)-145.81%

ROA(5y)-129.68%

ROE(3y)-183.8%

ROE(5y)-169.9%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y10.57%

GM growth 5Y13.61%

F-Score3

Asset Turnover0.57

Health

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	53.85%
Cap/Sales	4.52%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.01
Quick Ratio	3.6
Altman-Z	-59.68

F-Score3

WACC9.9%

ROIC/WACCN/A

Cap/Depr(3y)86.22%

Cap/Depr(5y)65.99%

Cap/Sales(3y)11.23%

Cap/Sales(5y)18.53%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)96.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.49%

EPS Next Y36.16%

EPS Next 2Y18.6%

EPS Next 3Y14.28%

EPS Next 5YN/A

Revenue 1Y (TTM)55.4%

Revenue growth 3Y45.73%

Revenue growth 5Y67.7%

Sales Q2Q%69.83%

Revenue Next Year103.47%

Revenue Next 2Y91.38%

Revenue Next 3Y76.45%

Revenue Next 5YN/A

EBIT growth 1Y19.23%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year33.9%

EBIT Next 3Y19.27%

EBIT Next 5YN/A

FCF growth 1Y20.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y20.26%

OCF growth 3YN/A

OCF growth 5YN/A

SENESTECH INC (SNES) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens